跳至主要内容
临床试验/NCT01952912
NCT01952912已完成不适用

Comparison of Plasmakinetic Enucleation of the Prostate With Open Prostatectomy for the Treatment of Benign Prostatic Hypertrophy Patients With Large Prostate

Fuzhou General Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
1
主要终点
Qmax at one year postoperatively

研究概览

简要总结

The investigators hypothesize that Plasmakinetic Enucleation of the Prostate (PkEP) might yield functional results comparable to OP but with lower perioperative morbidity, and have equivalent long-term efficacy with OP for large prostates. The first objective was to demonstrate the non-inferiority of PKEP compared to OP concerning Qmax at one year postoperatively.

To explore the long-term efficacy, we compared the efficacy, safety, and morbidity of PkEP with those of OP in BPH patients with prostate glands larger than 100 g over a follow-up period of 6 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • •Qmax < 12 mL/s, IPSS >19
  • Age between 50 and 70 years
  • Prostate volume larger than 100 mL, as determined by TRUS post-void residual urine volume greater than 50 ml medical therapy failure.

排除标准

  • •severe pulmonary disease or heart disease, coagulopathy, neurogenic bladder, bladder calculus, bladder cancer, prostate cancer, urethral stricture and previous prostate or urethral surgery

结局指标

主要结局

Qmax at one year postoperatively

时间窗: 1 year postoperatively

次要结局

  • Qmax at other time points after surgery(1, 3, 6, 24, 36, 48, 60 and 72 months postoperatively)
  • blood loss(perioperatively and on the first postoperative day)
  • duration of catheterization(after the operation)
  • length of postoperative hospital stay(after the operation)
  • PVR(1, 3, 6, 12, 24, 36, 48, 60 and 72 months postoperatively)
  • resected adenoma weight(right after the operation)
  • operation time(during the operation)
  • postoperative International Prostate Symptom Score(1, 3, 6, 12, 24, 36, 48, 60 and 72 months postoperatively)
  • QOL(1, 3, 6, 12, 24, 36, 48, 60 and 72 months postoperatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验